Anti-Inflammatory Drugs Reduce the Risk of Hepatocellular Carcinoma Development

ISRN Oncology
doi 10.5402/2011/390676
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Antenatal Exposure to Nonsteroidal Anti-Inflammatory Drugs and Risk of Neonatal Hypertension

Journal of Clinical Hypertension
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2018English

Safety and Efficacy of Non‐steroidal Anti‐inflammatory Drugs to Reduce Ileus After Colorectal Surgery

British Journal of Surgery
Surgery
2019English

The Effect of Non-Steroidal Anti-Inflammatory Drugs on Risk of Benign Prostatic Hyperplasia

European Urology, Supplements
Urology
2017English

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

British Medical Journal
Medicine
2013English

Extrapyramidal Reactions to Anti-Inflammatory Drugs.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1988English

Aspirin and Other Anti-Inflammatory Drugs

Thorax
PulmonaryRespiratory Medicine
2000English

Use of Nonsteroidal Anti-Inflammatory Drugs and the Risk of First-Time Acute Myocardial Infarction

British Journal of Clinical Pharmacology
Pharmacology
2002English

Anti-Inflammatory Drugs for Rheumatoid Arthritis

BMJ
1976English

Risk Factors for Hepatocellular Carcinoma

Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy